All Cancer Microbiology articles
-
NewsHPV integration: Moving from carcinogenesis mechanisms to clinical applications
The clinical significance of HPV integration into the host genome is substantial, particularly in cervical cancer screening programs. Integration testing has emerged as a valuable triage tool for detecting high-grade cervical intraepithelial neoplasia (CIN III+).
-
NewsTargeted delivery of microRNA sponge short-hairpin RNA via VIR-inspired biotechnical vector
The Vir-inspired Biotechnical Vector (VIBV) is a novel hybrid platform that combines viral and non-viral elements with nanotechnology to enable personalized, tumor-specific gene therapy.
-
NewsMicrobiotica announces completion of recruitment in its international phase 1b trial of microbiome co-therapy
Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces that patient recruitment is complete in its advanced melanoma (MELODY-1) trial.
-
NewsBout of cystitis may signal presence of urogenital cancers in middle-aged adults
A bout of the common bladder infection, cystitis, may signal the presence of urogenital cancers—which affect parts of the body involved in reproduction and excretion—in middle aged adults, suggests research. The risks seem to be especially high within 3 months of infection.
-
NewsMicrobial allies: Bacteria help fight against cancer
An international team of scientists have discovered that microbes associated with tumours produce a molecule that can control cancer progression and boost the effectiveness of chemotherapy.
-
NewsResearchers uncover how COVID-19 may linger in cancer patients and affect treatment outcomes
New research is providing important insights into how COVID-19 persists in cancer patients even long after testing positive. Researchers studied three cancer patients who had undergone transplant therapies and were hospitalized with severe COVID-19 infections.
-
NewsMD Anderson and Nature to co-host conference on the tumor ecosystem
The University of Texas MD Anderson Cancer Center and Springer Nature will co-host a free, in-person conference to explore the latest research on the tumor ecosystem, highlighting how its components influence cancer development, progression, diagnosis and treatment.
-
NewsResearchers reveal infection risks oral mucositis poses to stem cell transplant patients, introduce a superior AI tool to predict them
Researchers have completed a series of studies that reveal how much painful mouth sores known as oral mucositis increase infection risks in stem cell transplant patients and how artificial intelligence can be used to more accurately predict those risks.
-
NewsBlood test identifies HPV-associated head and neck cancers up to 10 years before symptoms
Researchers show that a novel liquid biopsy tool called HPV-DeepSeek can identify HPV-associated head and neck cancer up to 10 years before symptoms appear.
-
NewsFrailty fuels gut imbalance and post-surgery gastrointestinal risks
Scientists found that residual intra-abdominal microbes, especially in frail patients, drive gastrointestinal complications after bladder cancer surgery.
-
NewsScientists unveil viral mechanism behind nasopharyngeal cancer spread
Researchers have discovered that the Epstein-Barr virus (EBV), a common human virus closely linked to nasopharyngeal carcinoma (NPC), can change the 3D structure of the human genome inside cancer cells, much like assembling building blocks.
-
NewsIn extensive sequencing study, scientists find few links between cancer and microbiome
Scientists say a study that sequenced human cancers found far less microbial DNA sequences than earlier studies reported in the same cancer tissue samples.
-
NewsDNA analysis shows colorectal cancer has unique microbial fingerprint
Colorectal cancer is unique in having its own microbial ‘fingerprint’ – according to new research that could help doctors better understand how this cancer develops, how aggressive it might be, and even how a patient might respond to treatment.
-
NewsResearchers develop first-of-its-kind RNA tool to advance cancer and infectious disease research and treatment
Scientists have developed a powerful tool capable of scanning thousands of biological samples to detect transfer ribonucleic acid (tRNA) modifications — tiny chemical changes to RNA molecules that help control how cells grow, adapt to stress and respond to diseases such as cancer and antibiotic‑resistant infections.
-
NewsReview explores critical role of microbiome in cancer development and treatment
The human microbiome plays a pivotal role in cancer initiation, progression, and treatment response, according to a major review article published in the open-access journal iMeta. The study, led by an international team of researchers, details how bacteria, viruses, and fungi interact with tumors and the immune system to either promote or inhibit cancer growth.
-
NewsTherapeutic vaccination against HPV-related tumors: Nanoparticles make the difference
Researchers have developed a therapeutic vaccination concept that can mobilize the immune system to target cancer cells. Virus peptides coupled to silica nanoparticles can elicit effective T-cell responses against HPV-related tumors. In a mouse model, the nanoparticle-based vaccine was able to partially or completely suppress HPV-related tumors.
-
NewsGuideline on respiratory infections in leukemia revised
People with leukemia have a weakened immune system due to the disease itself and treatment, which leads to an increased susceptibility to infections. In a revised guideline, experts summarize the findings of the past ten years on all viruses that cause respiratory infections.
-
NewsMERIT grant awarded to study cure for HIV
A scientific team has received an NIH MERIT Award to provide long-term grant support to study a handful of people who have managed to clear HIV after a stem cell transplant and those who did not.
-
NewsGI tumor microbes may predict prognosis and inform treatment
Intratumor microbes can play a role in disease progression and response to treatment. Researchers have identified core tumor microbiota associated with disease progression and risk, developing a microbiota-based risk score that can predict response to therapy.
-
NewsAncient viruses in human genomes offer new avenue for stopping cancers, autoimmune diseases, and more
Researchers have revealed the first three-dimensional structure of a protein from an ancient human endogenous retrovirus (HERV) found within the human genome.